Scarica l'app Stockscreener
121.51
4.01%
4.69
Dopo l'orario di chiusura:
122.67
1.16
+0.95%
Halozyme Therapeutics Inc Azioni (HALO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
27.68%
481.00
|
376.71 | 451.77 | 354.26 | 325.72 |
| Cost Of Revenue |
0.08%
79.17
|
79.24 | 78.77 | 55.24 | 46.36 |
Selling, General, and Administrative
|
1.53%
57.00
|
57.88 | - | - | - |
| Costs And Expenses |
0.60%
193.34
|
192.19 | 544.66 | 136.34 | 123.28 |
| Operating Income/Loss |
55.90%
287.65
|
184.52 | -92.89 | 217.92 | 202.44 |
| Income/Loss From Continuing Operations Before Tax |
57.99%
284.90
|
180.33 | -100.85 | 218.96 | 204.94 |
| Income Tax Expense/Benefit |
81.61%
54.99
|
30.28 | 40.74 | 43.73 | 39.78 |
| Net Income/Loss |
53.23%
229.91
|
150.05 | -141.59 | 175.22 | 165.16 |
| Basic Average Shares |
0.74%
117.27
|
118.14 | -0.73 | 117.22 | 121.34 |
| Diluted Average Shares |
1.35%
121.22
|
122.88 | -0.545 | 122.33 | 124.16 |
| Basic Earnings Per Share |
54.33%
1.96
|
1.27 | -1.16 | 1.49 | 1.36 |
| Diluted Earnings Per Share |
55.74%
1.90
|
1.22 | -1.12 | 1.43 | 1.33 |
2.28%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):